To determine whether RPL29 is a functional mediator in PRMT1 regulation of LSCs, we restored RPL29 expression in PRMT1‐silenced CML CD34+ cells (Figure 5F) and performed a CFC/replating assay. Here, RPL29 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.